Perspective Therapeutics, Inc.
CATX
$2.12
-$0.08-3.43%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.80M | -94.95M | -73.47M | -67.58M | -52.08M |
| Total Depreciation and Amortization | 3.65M | 3.55M | 2.81M | 2.44M | 999.00K |
| Total Amortization of Deferred Charges | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Total Other Non-Cash Items | 28.86M | 28.73M | 27.02M | 26.15M | 15.05M |
| Change in Net Operating Assets | -10.44M | -1.40M | -482.00K | 30.30M | 44.23M |
| Cash from Operations | -84.43M | -64.78M | -53.72M | -18.29M | -696.00K |
| Capital Expenditure | -22.29M | -50.01M | -48.98M | -53.40M | -38.87M |
| Sale of Property, Plant, and Equipment | 335.00K | 335.00K | 335.00K | 335.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.96M | -119.97M | -125.26M | -162.57M | -38.25M |
| Cash from Investing | -125.91M | -169.64M | -177.20M | -218.93M | -80.42M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51.00K | -54.00K | -41.00K | -40.00K | -40.00K |
| Issuance of Common Stock | 10.36M | 10.78M | 10.63M | 166.98M | 167.35M |
| Repurchase of Common Stock | -287.34M | -287.34M | -287.34M | -287.34M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.06M | 288.06M | 288.06M | 288.06M | 0.00 |
| Cash from Financing | 10.66M | 11.08M | 133.03M | 289.39M | 289.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.68M | -223.34M | -97.89M | 52.16M | 208.28M |